Markets optimistic but ‘mistakenly euphoric’, says Kotak Institutional Equities

Markets optimistic but ‘mistakenly euphoric’, says Kotak Institutional Equities

Mumbai: Kotak Institutional Equities said the Indian market continues to be a mix of being “rightfully optimistic and mistakenly euphoric“. The brokerage said parts of the market rightfully reflect the strength of the Indian economy and its long-term growth prospects, while the other parts reflect “extreme euphoria linked to baseless narratives.” Kotak said the market … Read more

As China moves away from zero-Covid, health experts warn of dark days ahead | CNN

As China moves away from zero-Covid, health experts warn of dark days ahead | CNN

Editor’s Note: Editor’s Note: A version of this story appeared in CNN’s Meanwhile in China newsletter, a three-times-a-week update exploring what you need to know about the country’s rise and how it impacts the world. Sign up here. Hong Kong CNN  —  China’s zero-Covid policy, which stalled the world’s second-largest economy and sparked a wave … Read more

‘Free’ Screening? Know Your Rights to Get No-Cost Care

‘Free’ Screening? Know Your Rights to Get No-Cost Care

By Julie Appleby, Kaiser Health News Wednesday, July 06, 2022 (Kaiser News) — An ounce of prevention … well, you know the rest. In medicine, prevention aims to spot problems before they worsen, affecting both a patient’s health and finances. One of the more popular parts of the Affordable Care Act, which allows patients to … Read more

Johnson & Johnson plans to split into two companies

Johnson & Johnson plans to split into two companies

Johnson & Johnson said on Friday that it is planning to break up into two companies, splitting off its consumer health division that sells Band-Aids and Baby Powder from its large pharmaceuticals unit. The healthcare company will separate its consumer health business into a new publicly traded company and is aiming to complete the planned … Read more

A Pill to Treat COVID Could Be Just Months Away

A Pill to Treat COVID Could Be Just Months Away

By JoNel Aleccia, Kaiser Health News Friday, September 24, 2021 (Kaiser News) — Within a day of testing positive for covid-19 in June, Miranda Kelly was sick enough to be scared. At 44, with diabetes and high blood pressure, Kelly, a certified nursing assistant, was having trouble breathing, symptoms serious enough to send her to … Read more

CVS, Walgreens Wasted More Vaccine Than Many States

CVS, Walgreens Wasted More Vaccine Than Many States

By Joshua Eaton and Rachana Pradhan Monday, May 03, 2021 (Kaiser News) — Two national pharmacy chains that the federal government entrusted to inoculate people against covid-19 account for the lion’s share of wasted vaccine doses, according to government data obtained by KHN. The Centers for Disease Control and Prevention recorded 182,874 wasted doses as … Read more

U.S. Vaccine Safety System Still Has Gaps

U.S. Vaccine Safety System Still Has Gaps

By JoNel Aleccia, Kaiser Health News Monday, May 03, 2021 (Kaiser News) — The quick detection of an ultra-rare blood clotting reaction in some covid-19 vaccine recipients showed the power of a federal warning system for vaccine safety issues, but experts worry that blind spots in the program could hamper detection of other unexpected side … Read more

Doctors Prescribing Opioids to COVID ‘Long Haulers’

Doctors Prescribing Opioids to COVID ‘Long Haulers’

Wednesday, April 28, 2021 (Kaiser News) — Covid survivors are at risk from a possible second pandemic, this time of opioid addiction, given the high rate of painkillers being prescribed to these patients, health experts say. A new study in Nature found alarmingly high rates of opioid use among covid survivors with lingering symptoms … Read more

Strides Against HIV/AIDS Falter During Pandemic

Strides Against HIV/AIDS Falter During Pandemic

By Sarah Varney, Kaiser Health News Wednesday, April 21, 2021 (Kaiser News) — Facing a yearlong siege from the coronavirus, the defenses in another, older war are faltering. For the last two decades, HIV/AIDS has been held at bay by potent antiviral drugs, aggressive testing and inventive public education campaigns. But the COVID-19 pandemic … Read more